Can hydroxyzine (hydroxyzine) pamoate increase the risk of dementia in teenagers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxyzine and Risk of Dementia in Teenagers

There is no evidence that hydroxyzine pamoate increases the risk of dementia specifically in teenagers, but caution is warranted as first-generation antihistamines with anticholinergic effects have been associated with cognitive decline in older adults.

Hydroxyzine's Effects on Cognition

  • Hydroxyzine is a first-generation antihistamine with sedative and anxiolytic properties that is approved for use in both Europe and the United States 1
  • First-generation antihistamines like hydroxyzine have been associated with cognitive decline primarily in elderly populations, not specifically in teenagers 1
  • Cognitive concerns with hydroxyzine and similar medications are related to their anticholinergic effects, which can affect memory and cognitive function 1

Evidence Regarding Hydroxyzine in Younger Populations

  • Guidelines mention hydroxyzine as having few contraindications in children when used for anxiolysis in pediatric settings 1
  • Hydroxyzine is commonly used in pediatric populations for anxiety management during medical procedures with acceptable safety profiles 1
  • The most common side effects reported in younger populations include sedation and drowsiness, not long-term cognitive impairment 2, 3

Risk Factors for Cognitive Effects

  • Anticholinergic burden (cumulative effect of multiple medications with anticholinergic properties) is a more significant concern than any single medication 1
  • Long-term use of medications with anticholinergic effects is more concerning than short-term or intermittent use 1
  • Risk of cognitive effects appears to be age-dependent, with elderly patients being most vulnerable 1

Comparative Safety Profile

  • Hydroxyzine has fewer safety concerns in adolescents compared to benzodiazepines, which are often not recommended in children under 16 years of age 1
  • When compared to other sedative options for pediatric patients, hydroxyzine has a relatively favorable safety profile 1
  • In studies examining hydroxyzine for anxiety disorders, the most common side effects were transient sleepiness rather than cognitive impairment 2, 3

Monitoring and Precautions

  • Patients should be monitored for cognitive effects, particularly with long-term use 1
  • Lower doses should be considered when possible to minimize anticholinergic burden 1
  • Avoid combining hydroxyzine with other medications that have anticholinergic properties to prevent cumulative effects 1

Clinical Considerations

  • For teenagers requiring anxiolysis, non-pharmacological approaches should be considered first when appropriate 1
  • If medication is necessary, second-generation antihistamines with less anticholinergic activity may be preferable for long-term use 1
  • When hydroxyzine is used, the lowest effective dose should be prescribed for the shortest duration necessary 1

Common Pitfalls

  • Failing to recognize that sedation and cognitive impairment are distinct side effects with different risk profiles 1
  • Overlooking the potential for drug interactions that may increase anticholinergic burden 1
  • Not distinguishing between short-term cognitive effects (sedation) and potential long-term cognitive concerns 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.